Skip to main content

Want a detailed portfolio tracker?

CELU
NASDAQ
$0.78

Celularity Inc - Class A (CELU)

Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta. The company is advancing a promising pipeline of allogeneic immunotherapies aimed at enhancing treatment outcomes for cancer patients and those with severe medical conditions, while reducing associated complications. With a strong leadership team and strategic partnerships, Celularity is positioned to become a significant force in the dynamic advanced therapeutics sector, addressing critical unmet medical needs and driving advancements in patient care.
Website: https://www.celularity.com
Sector:
Healthcare
Industry:
Biotechnology
Target: $2.50 (+220.51%)

Market Cap

$22M

FCF 5Y CAGR

+51.20%

Free Cash Flow Yield

-58.92%

Beta (5Y)

1.47

Price Chart

Valuation
Market Cap$22M
P/S0.85
P/B9.89
Profitability
Total Revenue (TTM)$27M
Gross Profit (TTM)$6.48M
EBITDA-$54M
Operating Margin-492.1%
EPS-$3.48
Financial Health
Free Cash Flow Yield-58.92%
Growth & Risk
Revenue 5Y CAGR+13.21%
FCF 5Y CAGR+51.20%
Beta (5Y)1.47
Sharpe Ratio-0.54